Inhaled corticosteroid–long-acting beta-agonist (ICS-LABA) inhalers are widely prescribed for asthma and chronic obstructive pulmonary disease. ICS-LABAs are largely interchangeable within the class; ...
The rollout of the updated inhalers is set for 2026 ...
Hosted on MSN
More than a million people now using new asthma medication rather than traditional blue inhalers
Health officials are calling on all providers to move away from prescribing traditional blue inhalers to asthma patients, in a 'life-saving' shift in how the condition is treated. It comes after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results